In this study, 48.3, 27.3, 14.9 and 58% of patients receiving insulin were having CVD, retinopathy, nephropathy and neuropathy, respectively compared to 29, 12.5, 4.4 and 22.8% in patients using OHA (p < 0.001). This evidence concerns the gene INS and kidney disorder.